3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Burkitt Lymphoma
1
Anus Neoplasms
1
Interventions
Rituximab
15
Cyclophosphamide
10
Lenalidomide
8
venetoclax
7
Magnetic Resonance Spectroscopy
7
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
Prednisone
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
CT-P10
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Etoposide
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Diphenhydramine
×
90 days
×
Clear all
No trials found.